These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 16185871

  • 21. Utility of intraoperative frozen section examination of sentinel lymph nodes in ductal carcinoma in situ of the breast.
    Ballehaninna UK, Chamberlain RS.
    Clin Breast Cancer; 2013 Oct; 13(5):350-8. PubMed ID: 23791128
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.
    van la Parra RF, Ernst MF, Barneveld PC, Broekman JM, Rutten MJ, Bosscha K.
    Eur J Surg Oncol; 2008 Jun; 34(6):631-5. PubMed ID: 17851019
    [Abstract] [Full Text] [Related]

  • 30. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
    Han JS, Molberg KH, Sarode V.
    Breast J; 2011 Jun; 17(3):223-9. PubMed ID: 21545433
    [Abstract] [Full Text] [Related]

  • 31. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
    Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova E.
    Cancer; 2006 Oct 15; 107(8):1760-8. PubMed ID: 16977650
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida.
    Camp R, Feezor R, Kasraeian A, Cendan J, Schell S, Wilkinson E, Copeland E, Lind S.
    Breast J; 2005 Oct 15; 11(6):394-7. PubMed ID: 16297082
    [Abstract] [Full Text] [Related]

  • 35. Tumour-positive sentinel node findings in patients with ductal carcinoma in situ.
    Leidenius M, Salmenkivi K, von Smitten K, Heikkilä P.
    J Surg Oncol; 2006 Oct 01; 94(5):380-4. PubMed ID: 16967467
    [Abstract] [Full Text] [Related]

  • 36. Sentinel lymph node biopsy in the management of ductal carcinoma in situ.
    Zujewski J, Eng-Wong J.
    Clin Breast Cancer; 2005 Aug 01; 6(3):216-22. PubMed ID: 16137431
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pathological classification of DCIS and planning of therapeutic management.
    Buonomo O, Orsaria P, Contino G, Varvaras D, Gioia A, Bonanno E, Pistolese C, Cossu E, Perretta T, Schillaci O, Del Monte G, Roselli M, Mineo TC, Petrella G.
    Anticancer Res; 2009 May 01; 29(5):1499-506. PubMed ID: 19443357
    [Abstract] [Full Text] [Related]

  • 39. Risk factor for axillary lymph node metastases in microinvasive breast cancer.
    Ko BS, Lim WS, Kim HJ, Yu JH, Lee JW, Kwan SB, Lee YM, Son BH, Gong GY, Ahn SH.
    Ann Surg Oncol; 2012 Jan 01; 19(1):212-6. PubMed ID: 21633867
    [Abstract] [Full Text] [Related]

  • 40. What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ?
    Mabry H, Giuliano AE, Silverstein MJ.
    Am J Surg; 2006 Oct 01; 192(4):455-7. PubMed ID: 16978948
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.